NZ187333A - 2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles - Google Patents

2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles

Info

Publication number
NZ187333A
NZ187333A NZ187333A NZ18733378A NZ187333A NZ 187333 A NZ187333 A NZ 187333A NZ 187333 A NZ187333 A NZ 187333A NZ 18733378 A NZ18733378 A NZ 18733378A NZ 187333 A NZ187333 A NZ 187333A
Authority
NZ
New Zealand
Prior art keywords
fluoro
compound according
hydrogen
trans
hexahydro
Prior art date
Application number
NZ187333A
Other languages
English (en)
Inventor
W Mck Welch Jr
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of NZ187333A publication Critical patent/NZ187333A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NZ187333A 1977-05-23 1978-05-22 2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles NZ187333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79939277A 1977-05-23 1977-05-23

Publications (1)

Publication Number Publication Date
NZ187333A true NZ187333A (en) 1984-05-31

Family

ID=25175793

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ187333A NZ187333A (en) 1977-05-23 1978-05-22 2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles

Country Status (31)

Country Link
JP (1) JPS53144600A (cs)
AR (2) AR217688A1 (cs)
AT (1) AT368995B (cs)
AU (1) AU499618B1 (cs)
BE (1) BE867249A (cs)
CA (1) CA1094071A (cs)
CH (1) CH634321A5 (cs)
CS (1) CS207612B2 (cs)
DD (4) DD138321A5 (cs)
DE (1) DE2822465C2 (cs)
DK (1) DK226678A (cs)
EG (1) EG13590A (cs)
FI (1) FI63402C (cs)
FR (1) FR2392023A1 (cs)
GB (1) GB1586655A (cs)
GR (1) GR69985B (cs)
HU (3) HU185009B (cs)
IE (1) IE46975B1 (cs)
IL (1) IL54755A (cs)
IT (1) IT1096307B (cs)
LU (1) LU79684A1 (cs)
NL (1) NL7804210A (cs)
NO (2) NO150204C (cs)
NZ (1) NZ187333A (cs)
PH (1) PH13756A (cs)
PL (5) PL114547B1 (cs)
PT (1) PT68058B (cs)
SE (2) SE441448B (cs)
SU (4) SU873883A3 (cs)
YU (4) YU91478A (cs)
ZA (1) ZA782918B (cs)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4224329A (en) * 1979-01-23 1980-09-23 Pfizer Inc. 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
US4451655A (en) * 1982-05-17 1984-05-29 Pfizer Inc. Process for preparing carboline derivatives and compounds used in their preparation
RU2106864C1 (ru) * 1995-10-23 1998-03-20 Николай Серафимович Зефиров Средство для лечения болезни альцгеймера
SE9604786D0 (sv) 1996-12-20 1996-12-20 Astra Pharma Inc New compounds
US6974825B1 (en) 1996-12-20 2005-12-13 Astrazeneca Canada Inc. Compounds with analgesic effect
SE9904675D0 (sv) 1999-12-20 1999-12-20 Astra Pharma Inc Novel compounds
SE0101773D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101771D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101770D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds
SE0101769D0 (sv) 2001-05-18 2001-05-18 Astrazeneca Ab Novel compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR205452A1 (es) * 1973-12-06 1976-05-07 Endo Lab Metodo para preparar nuevos trans-2, 3, 4, 4a, 5, 9b-hexahidro-5-fenil-1h-pirido(4,3-b) indoles
JPS50126699A (cs) * 1974-03-20 1975-10-04
US4001263A (en) * 1974-04-01 1977-01-04 Pfizer Inc. 5-Aryl-1,2,3,4-tetrahydro-γ-carbolines

Also Published As

Publication number Publication date
HU185009B (en) 1984-11-28
YU91478A (en) 1983-01-21
CH634321A5 (en) 1983-01-31
IL54755A (en) 1981-02-27
SU873883A3 (ru) 1981-10-15
YU221682A (en) 1983-01-21
IE46975B1 (en) 1983-11-16
SU818484A3 (ru) 1981-03-30
NL7804210A (nl) 1978-11-27
NO831790L (no) 1978-11-24
NO150204B (no) 1984-05-28
PT68058B (en) 1979-10-24
IE781013L (en) 1978-11-23
IT1096307B (it) 1985-08-26
DD146186A5 (de) 1981-01-28
YU221882A (en) 1983-01-21
DD145536A5 (de) 1980-12-17
ATA369678A (de) 1982-04-15
PT68058A (en) 1978-06-01
AR217688A1 (es) 1980-04-15
FR2392023A1 (fr) 1978-12-22
DD138321A5 (de) 1979-10-24
GR69985B (cs) 1982-07-22
JPS53144600A (en) 1978-12-15
CA1094071A (en) 1981-01-20
JPS5711912B2 (cs) 1982-03-08
SE8305917D0 (sv) 1983-10-27
SU841589A3 (ru) 1981-06-23
EG13590A (en) 1982-03-31
SE448459B (sv) 1987-02-23
ZA782918B (en) 1979-06-27
NO781770L (no) 1978-11-24
PL114547B1 (en) 1981-02-28
PH13756A (en) 1980-09-17
DD145537A5 (de) 1980-12-17
BE867249A (fr) 1978-11-20
HU187782B (en) 1986-02-28
NO151862B (no) 1985-03-11
AT368995B (de) 1982-11-25
AU499618B1 (en) 1979-04-26
SE441448B (sv) 1985-10-07
NO151862C (no) 1985-06-19
GB1586655A (en) 1981-03-25
DK226678A (da) 1978-11-24
SE8305917L (sv) 1983-10-27
FI63402B (fi) 1983-02-28
HU188802B (en) 1986-05-28
FI63402C (fi) 1983-06-10
CS207612B2 (en) 1981-08-31
NO150204C (no) 1984-09-05
PL117107B1 (en) 1981-07-31
DE2822465A1 (de) 1978-11-30
LU79684A1 (fr) 1979-12-06
DE2822465C2 (de) 1986-08-28
YU221782A (en) 1983-01-21
IL54755A0 (en) 1978-07-31
PL114541B1 (en) 1981-02-28
SU843749A3 (ru) 1981-06-30
PL116944B1 (en) 1981-07-31
IT7823673A0 (it) 1978-05-22
FI781612A7 (fi) 1978-11-24
YU40796B (en) 1986-06-30
AR221721A1 (es) 1981-03-13
FR2392023B1 (cs) 1980-11-07
PL206903A1 (pl) 1979-10-22
SE7803625L (sv) 1978-11-24

Similar Documents

Publication Publication Date Title
CA1056381A (en) 5-ARYL-1,2,3,4-TETRAHYDRO-.gamma.-CARBOLINES
US4423044A (en) 3,4-Dihydro-5H-2,3-benzodiazepine derivatives and pharmaceutical use thereof
JPH0549668B2 (cs)
US4224329A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
EP0306871A2 (de) 3,7-Diazabicyclo [3,3,1] nonan-Verbindungen sowie Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
JPS58185554A (ja) エタノ−ルアミン誘導体、その製法及びそれを含む製薬組成物
US4420480A (en) Hexahydronaphth[1,2-b]-1,4-oxazines
NZ187333A (en) 2-substituted-trans-2,3,4,4a,5,9b-hexahydro-1h-pyrido-(4,3-b)indoles
JPH02504394A (ja) フロ〔３，４‐ｃ〕ピリジン鏡像体の立体特異的製造方法、かくして得られた化合物及びこれの製薬組成物
US5958927A (en) Indanol compounds
US3328411A (en) Novel piperidine derivatives
DE3151201A1 (de) Substituierte phenoxyalkanolamine und phenoxyalkanol-cycloalkylamine, verfahren zu ihrer herstellung, diese verbindungen enthaltende pharmazeutische zubereitungen und zwischenprodukte
US4252812A (en) 2-Substituted-trans-5-aryl-2,3,4,4a,5,9b-hexahydro-1H-pyrido[4,3-b]indoles
EP0237169A1 (en) 5-Substituted octahydroindolizine analgesics compounds and 7-keto intermediates
JPH037280A (ja) 新規ベンゾチオピラニルアミン
US4267331A (en) Process for the production of 2-substituted pyrido[4,3-b]-indoles
JPS60120853A (ja) １−（４′−アルキルチオフエニル）−２−アミノ−１，３−プロパンジオ−ルｎ−置換誘導体
US4927819A (en) Cyclo-octane neuroprotective agents
EP0001585B1 (de) Piperazino-pyrrolobenzodiazepine, Verfahren zu ihrer Herstellung sowie pharmazeutische Präparate enthaltend diese Verbindungen
US3712946A (en) Certain oxy-substituted benzo quinolizinium compounds and their use
US4003936A (en) 2-Hydrocinnampyl-1,3-cyclopentanediones
US4044137A (en) 2-(Phenylthiopropyl)-5-aryl-1,2,3,4-tetrahydro-γ-carbolines
DE3882956T2 (de) Gegen die zerebrale Insuffizienz wirksame Verbindungen.
AT375079B (de) Verfahren zur herstellung von neuen trans-2,3,4,4a ,5,9b-hexahydro-1h-pyrido(4,3-b)indolen und ihren pharmazeutisch annehmbaren salzen
PL110223B1 (en) Method of producing new compounds of pyrido/1,2-a/pyrimidine